Injectable drugs and infusion technologies provider Hospira has obtained 510(k) approval from the US Food and Drug Administration (FDA) for the Plum 360 infusion system with Hospira MedNet safety software.
The Plum 360 infusion system with Hospira MedNet safety software has been developed to improve the efficiency of intravenous (IV) medication administration.
Based on the air management and secondary delivery features of Plum A+, the new infusion device is said to expand the firm’s drug library and wireless capability to enable streamlined electronic medical record (EMR) integration.
Hospira Medical Devices president David Endicott said: "Hospira is excited to announce clearance of the Plum 360 infusion system in the US — another important milestone in our continued path to streamline and modernize our device portfolio.
"Hospira will continue to develop and launch the most technologically advanced infusion pumps in the industry for our customers and patients."
The second delivery feature of the system allows the pump to differentiate between primary and secondary infusion lines and deliver each as intended, and its improved wireless communication will accelerate drug library updates and optimize EMR connectivity with automated programming and documentation.
The firm’s other product portfolio includes Plum A+ infusion system, Sapphire ambulatory infusion system, SapphirePlus large-volume general-infusion device and LifeCare PCA pain management pump with Hospira MedNet.